WASHINGTON (AP) — The US Food and Drug Administration advisory panel now endorses booster doses of Johnson & Johnson's single-shot COVID-19 vaccine.
The decision came via a unanimous Friday vote by the panel.
The booster is recommended at least two months after people receive the first dose.
A portion of this story is shared with you as a digital media exclusive. The full story will be available tomorrow for subscribers. Please consider supporting our local, independent newsroom by subscribing at butlereagle.com.